The shift towards alternative protein, an investor’s perspective

Big Idea Ventures

Investors are constantly looking out for innovation within the alternative protein industry, including plant-based and cell-based technology. Big Idea Ventures (BIV) supports the world’s best entrepreneurs, scientists, and engineers. We have invested more than 40 companies in the alternative protein sector and will be highlighting several technologies that are established by our portfolio companies.


Question 1: What drives you?
Solving the worlds greatest challenges by supporting its greatest entrepreneurs

Question 2: Why should the delegate attend your presentation?
Big Idea Ventures is a global leader in alternative proteins with an investment fund of +50M USD and accelerator locations in New York City and Singapore

Question 3: What emerging technologies/trends do you see as having the greatest potential in the short and long run?
Precision fermentation in the short term and cell-based products in the long term

Question 4: What kind of impact do you expect them to have?
The ability to create great tasting meat, seafood, and dairy that we’ve grown up loving in a far more sustainable way for us and the planet.

Question 5: What are the barriers that might stand in the way?
Scalability, funding, regulations, and environmental obstacles

About Andrew Ive
Andrew is the founder of Big Idea Ventures. It’s purpose is to solve the world’s biggest challenges by supporting the world’s best entrepreneurs. Our first fund + accelerator (NY & Singapore) invests in plant-based foods and ingredients to impact climate change, animal welfare and personal health. Investors include Tyson Foods & Temasek. Advisory Board member for Tufts Nutrition Council. Our second fund is focused on reducing CO2, plastics, waste and water in the food industry. Friedman School Entrepreneurship Advisor. Harvard Business School graduate, Procter & Gamble brand management trained.

About big Idea Ventures
Big Idea Ventures is a hybrid venture firm: Our first fund is the New Protein Fund, which is raising up to USD$50M to invest in the best companies in the plant-based foods and alternative protein ecosystem. We combine capital and partnership to support and grow the world’s most compelling plant based food companies and protein alternatives. Our first investment is into Shiok Meat which is the first clean meat company in Asia and first to have graduated from Y Combinator.

We are fortunate to be anchored by major institutional investors including Tyson Foods (NYSE: TSN) a Fortune 100 company with expected US$43B in revenue for 2019 as well as Temasek which is a global investment company headquartered in Singapore which owns a US$235B portfolio as of 31 March 2018.

Andrew Ive will be speaking at the 2021 edition of the Protein Transition Conference.

Leave a Reply